Cardio Diagnostics Holdings, Inc. (CDIO) vs Femasys Inc. (FEMY)
A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Femasys Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDIO
Cardio Diagnostics Holdings, Inc.
$2.03HealthcareDelayed quote: Oct 6, 2026, 11:52 AM EDT
FEMY
Femasys Inc.
$2.09HealthcareDelayed quote: Oct 6, 2026, 11:52 AM EDT
Total return — CDIO vs FEMY
growth of $100 · dividends reinvested · last 5yCDIO -99.3% (-62.9%/yr)FEMY -96.8% (-49.8%/yr)FEMY compounded faster over this window
CDIO FEMY
CDIO vs FEMY: by the numbers
- •FEMY is the larger company ($6M vs $6M market cap).
- •Both run net losses; FEMY's is the smaller (-534.27% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | CDIO | FEMY |
|---|---|---|
| P/S ratio | 415.76 | 2.74 |
| P/B ratio | 0.81 | 1.57 |
Profitability
| Metric | CDIO | FEMY |
|---|---|---|
| Gross margin | 100.00% | 61.96% |
| Operating margin | -43737.46% | -763.90% |
| Net margin | -44771.83% | -534.27% |
| ROE | -87.12% | -304.78% |
| ROIC | -82.84% | -209.05% |
Growth (annualized)
| Metric | CDIO | FEMY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.97% |
| Total return CAGR (5Y) | N/A | -57.27% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.